Cevostamab (Anti- FcRH5 / IRTA2 / CD307e)

Cevostamab (Anti- FcRH5 / IRTA2 / CD307e) is a humanized IgG1-based bispecific antibody that targets membrane-proximal extracellular domain of FcRH5 on multiple myeloma (MM) cells as well as CD3 on T cells. MW: 145.24 kD.

• Supplier: Selleck Chemicals
• Product #: A2746
• Sku #: A2746-1mg*5